14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:IMNP
Delisted

Immune Pharmaceuticals Inc. Stock Predictions

$0.0032
+0 (+0%)
At Close: Mar 05, 2019
Currently predicting for Wed, 8 May 2024

Trading levels for IMNP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0032 .
R2 0.0032 .
R1 0.0032 .
Current price: 0.0032
Support S1 0.0032 .
S2 0.0032 .
S3 0.0032 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0039 21.88 %
R2 0.0037 15.63 %
R1 0.0034 6.25 %
Current price 0.0032
Support S1 0.0030 -6.25%
S2 0 .
S3 0 .

IMNP Predictions History

7 years ago
Aberra predicted that IMNP for 2017-01-05 is going $0.180 (-95.00%)

7 years ago
Abdu predicted that IMNP for 2017-01-04 is going $0.180 (-95.00%)

7 years ago
Aberra predicted that IMNP for 2017-01-04 is going $0.180 (-95.00%)

7 years ago
Aberra predicted that IMNP for 2017-01-03 is going $0.180 (-95.00%)

7 years ago
Abdu predicted that IMNP for 2017-01-03 is going $0.180 (-95.00%)

7 years ago
Aberra predicted that IMNP for 2016-12-30 is going $0.180 (-95.00%)

7 years ago
Abdu predicted that IMNP for 2016-12-30 is going $0.180 (-95.00%)

7 years ago
Abdu predicted that IMNP for 2016-12-19 is going $0.180 (-95.00%)

7 years ago
Abdu predicted that IMNP for 2016-12-13 is going $0.230 (-94.25%)

7 years ago
AJR predicted that IMNP for 2016-12-13 is going $0.239 (-94.57%)

Rank:
Click to get the best stock tips daily for free!

About Immune Pharmaceuticals Inc.

Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company’s lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn's disease. It is also developing NanoCyclo, a topical nanocapsule formulati... IMNP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT